ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Continuing the fight against antimicrobial resistance
Shelley Mclendon, Vice President, Vaccine and Infectious Disease, offers her insights on the necessary actions to combat the threat of AMR.
Health technology assessments: understanding the global landscape and considerations for drug development
Manpreet Sidhu and Ben Cieply share insights on how HTAs inform decisions for market access and reimbursement of new pharmacotherapies.
Will big tech dominate healthcare in the years ahead?
Louisa Roberts, VP of Corporate Development and Partnerships, considers the benefits of partnerships with tech companies.
Identifying integrated digital platforms designed for a decentralised future
Matt Harrington explores how the use of digital platforms and associated services can contribute to more adaptable, accessible and efficient clinical trials.
Patient centricity in insulin injection: Using technology to improve self-administration
David T. Novotny considers the current and future developments in injection technology.
Putting patients at the heart of clinical trials
Scott Palmese, Senior Director, Accellacare Site Network, shares his insights on optimising the patient experience within clinical trials, and the ramifications of the COVID-19 pandemic.
Embedded blended solutions - A new way to optimise clinical trial portfolio delivery
John Barry and Brian Swindley offer their insights on the options available to pharma companies when delivering their clinical trial portfolios.
Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity
Emily Mitchell discusses the importance of considering the target patient population when designing and deploying a decentralised clinical trial.
Triangle's CRO industry saw a flurry of M&A activity over past year
This article provides an overview of the mergers and acquisition activity across 2021 that have involved CROs based or heavily present in the North Carolina Triangle, which includes ICON’s $12bn acquisition of PRA Health Sciences.
Using cross-functional teams to develop a product's value story
Experts from the Commercial Solutions team discuss how essential a data-driven strategy is to successfully communicate a brand’s value proposition in a competitive market.